The pharma giant previously received billions in federal funding and raked in huge profits, but owes nothing in 2023 income taxes thanks to legal loopholes and Trump-era tax cuts.
Emfo LLC lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 54.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,221 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the quarter. Emfo LLC’s holdings in Pfizer […]
Illinois Municipal Retirement Fund trimmed its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 1.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 585,078 shares of the biopharmaceutical company’s stock after selling 9,694 shares during the period. Illinois Municipal Retirement […]
Rakuten Securities Inc. acquired a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 47,586 shares of the biopharmaceutical company’s stock, valued at approximately $1,370,000. Pfizer comprises about 1.1% of Rakuten Securities Inc.’s portfolio, making […]
Syon Capital LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 111.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,444 shares of the biopharmaceutical company’s stock after purchasing an additional 33,961 shares during […]
John G Ullman & Associates Inc. trimmed its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 29.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,708 shares of the biopharmaceutical company’s stock after selling 169,128 shares during the quarter. Pfizer […]
AlphaQ Advisors LLC purchased a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 8,174 shares of the biopharmaceutical company’s stock, valued at approximately $235,000. A number of other hedge funds have also recently […]
Cutter & CO Brokerage Inc. increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the […]
Resonant Capital Advisors LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 97,898 shares of the biopharmaceutical company’s stock after purchasing an additional 9,762 shares during the quarter. Resonant Capital […]
Northstar Asset Management LLC reduced its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 26,492 shares of the biopharmaceutical company’s stock after selling 1,150 shares during the quarter. Northstar […]
Louisiana State Employees Retirement System acquired a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 341,400 shares of the biopharmaceutical company’s stock, valued at approximately $9,829,000. A number of other hedge funds have also […]
Investors Asset Management of Georgia Inc. GA ADV grew its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,890 shares of the biopharmaceutical company’s stock after purchasing an additional […]